Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05594264 · ClinicalTrials.gov registry record · NA
Storytelling Intervention for African Americans Living With Hypertension
A NA study, sponsored by University of Delaware.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05594264 is a NA study that was terminated before completion, run by University of Delaware. The registered enrollment target is 31 participants.
The verdict
NCT05594264, a NA study, was terminated before completion, sponsored by University of Delaware.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Narrative communication (e.g., storytelling) is an approach that has contributed to behavioral change for individuals with conditions such as diabetes, breast cancer, and hypertension. The objective of this study is to conduct a feasibility and pilot study storytelling intervention for African Americans with hypertension. In the feasibility phase 30 African Americans with hypertension will be recruited to view nine patient stories and provide feedback on the effectiveness, usefulness, and satisfaction with the stories. Nine African Americans adults with hypertension were filmed, sharing experiences living with and managing hypertension; including, diet and exercise tips, suggestions for locating healthy foods, and motivational stories about successfully controlling hypertension. During the feasibility phase feedback will also be elicited from the participants about the best approaches for delivering a storytelling intervention, and obtain feedback on the resources and health information that would be helpful to an individual participating in a storytelling intervention. In the pilot study phase, 30 African Americans adults with hypertension will be recruited to participate in a 6-week trial, each week the participants will watch one story and review one module of health information accessible through the study specific website developed for the High Blood Pressure Stories (HBPStories) study. Data will be collected at baseline and 6-weeks including systolic and diastolic blood pressure, medication adherence, health behaviors such as diet and physical activity, and psychosocial measures including positive affect and self-efficacy in the management of hypertension.
Interventions
- BEHAVIORAL HBPStories
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2023-06-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05594264
The ClinicalTrials.gov registry entry for NCT05594264 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HBPStories is the first listed.
NCT05594264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05594264 about?
NCT05594264 is a clinical study titled "Storytelling Intervention for African Americans Living With Hypertension". Narrative communication (e.g., storytelling) is an approach that has contributed to behavioral change for individuals with conditions such as diabetes, breast cancer, and hypertension. The objective of this study is to conduct a feasibility and pilot study storytelling intervention for African Ameri...
What is the current status of trial NCT05594264?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2022-07-14. Estimated completion is 2023-06-24.
What interventions are being tested in trial NCT05594264?
The interventions under investigation include: HBPStories (BEHAVIORAL).
Who is sponsoring clinical trial NCT05594264?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.